Active Ingredient (Active Ingredient)
A text panel titled 'Active ingredient' listing Ferric Sulfate at a concentration of 21% w/w as the active component.*
Stasis Solution
Product Images NDC 10129-031
13 FDA label images from Gingi-pak A Division Of The Belport · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Stasis (NDC 10129-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Directions (Directions)
Text directions for the use of STASIS (Ferric Sulfate) solution in dental procedures, describing application methods using cotton pellets, sponges, or syringes. It details soaking techniques for retraction cords, rinsing instructions before impressions, coagulation effects, and cautions against scrubbing or burnishing to protect gingival tissue.*
Inactive Ingredients (Inactive Ingredients)
A drug facts or ingredient text panel listing purified water, glycerin, and flavoring among ingredients. The text is a partial view, showing only these three components. No other details or product specifics are visible.*
Keep Out Of Reach Of Children (Keep Out Of Children)
A text panel displaying the warning statement 'Keep out of reach of children.' typically found on medication labels or packaging to ensure safety.*
Main Display 15ml
The packaging label for STASIS 21% Ferric Sulfate Topical Hemostatic Solution, 15 mL bottle. The label highlights the active ingredient concentration and multilingual identification of ferric sulfate solution. Manufactured by Gingi-Pak, located in Camarillo, CA, USA. The label includes an NDC number 10129-031-01, an epinephrine-free note, and storage temperature symbols.*
Main Display 40ml
STASIS 21% Ferric Sulfate Topical Hemostatic Solution in a 40 mL bottle. This dental, periodontal, and subgingival solution is epinephrine-free and manufactured by Gingi-Pak, a division of Belport, in Camarillo, California, USA. The label includes the proprietary name, strength, NDC 10129-031-02, multilingual ingredient description, and usage instructions.*
Precautions (Precautions 1)
A precautionary text panel for STASIS Ferric Sulfate solution indicates that temporary tissue discoloration may occur for 24 to 48 hours but will disappear. It also advises against combining Ferric Sulfate solutions like STASIS with epinephrine or epinephrine-containing products.*
Precautions (Precautions 2)
Text panel warning about the use of impregnated retraction materials, cautioning that long-term use may cause permanent staining. It states that stains on hands and clothing may generally be removed with 3% Hydrogen Peroxide.*
Purpose (Purpose)
A drug facts panel segment showing the 'Purpose' heading with the term 'Hemostyptic' below it, indicating the product's function as a hemostatic agent.*
Stop Use And Ask A Doctor (Stop Use And Ask A Doctor)
A text panel displaying a usage warning instructing to stop use and consult a doctor if irritation appears. The text emphasizes caution for consumers or patients.*
Storage (Storage)
This text panel provides storage instructions for STASIS ferric sulfate solution. It advises protecting the product from direct sunlight and storing it at room temperature. It notes crystallization may occur below 32°F (0°C) and states the solution can be warmed and agitated until dissolution without affecting potency.*
Uses (Uses)
A text panel titled 'Uses' describes the indication for a dental hemostatic solution. It states that the product is for control of bleeding or topical hemostasis in routine dental procedures including implantation, root canals, gingivectomy, frenectomy, tissue retraction, oral surgery, and crown and bridge preparations.*
Warning
A warnings and contraindications text panel for STASIS Ferric Sulfate 3150 mg/15mL solution. The panel advises external use only, avoiding eye contact, and not using if hypersensitive to ferric sulfate. It instructs to stop use and consult a doctor if irritation occurs and to keep out of children's reach. It notes no known contraindications and mentions mild gingival tissue irritation and risk of diarrhea from large ingested doses.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
